(Q61975731)

English

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma (English)

0 references

0 references

0 references

United States of America

0 references

start time

19 November 2012

0 references

end time

21 March 2016

0 references

number of participants

6

0 references

research intervention

fenofibrate / pravastatin

0 references

fenofibric acid

0 references

clinical trial phase

phase II clinical trial

0 references

research site

University of Miami

0 references

research subject recruitment status

terminated

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01965834

0 references

(Q61975731)

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)